Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
Pharmacokinetics, pharmacodynamics and tolerability of a potent, non-peptidic, GP IIb/IIIa receptor antagonist following multiple oral administrations of a prodrug form. [electronic resource] by
- Refino, C J
- Modi, N B
- Bullens, S
- Pater, C
- Lipari, M T
- Robarge, K
- Blackburn, B
- Beresini, M
- Weller, T
- Steiner, B
- Bunting, S
Producer: 19980312
In:
Thrombosis and haemostasis vol. 79
Availability: No items available.
|
|
|
4.
|
Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists. [electronic resource] by
- Robarge, K D
- Dina, M S
- Somers, T C
- Lee, A
- Rawson, T E
- Olivero, A G
- Tischler, M H
- Webb, R R
- Weese, K J
- Aliagas, I
- Blackburn, B K
Producer: 19990331
In:
Bioorganic & medicinal chemistry vol. 6
Availability: No items available.
|
|
|
5.
|
Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor. [electronic resource] by
- Wong, H
- Chen, J Z
- Chou, B
- Halladay, J S
- Kenny, J R
- La, H
- Marsters, J C
- Plise, E
- Rudewicz, P J
- Robarge, K
- Shin, Y
- Wong, S
- Zhang, C
- Khojasteh, S C
Producer: 20091228
In:
Xenobiotica; the fate of foreign compounds in biological systems vol. 39
Availability: No items available.
|